| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/23/2006 | CN1822835A Alkaline salts of proton pump inhibitors |
| 08/23/2006 | CN1822834A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 08/23/2006 | CN1822833A Use of 3,7-diazabicyclo not 3,3,1|nonane compounds for the treatment and/or prophylaxis of arrhythmic events in male human patients |
| 08/23/2006 | CN1822832A Use of novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same |
| 08/23/2006 | CN1822831A Semi-solid systems containing azetidine derivatives |
| 08/23/2006 | CN1822830A Emulsifying systems containing azetidine derivatives |
| 08/23/2006 | CN1822829A 7-carboxymethyloxy-3', 4', 5-trimethoxy flavone monohydrate, the preparation method and uses thereof |
| 08/23/2006 | CN1822828A Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments |
| 08/23/2006 | CN1822827A Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition |
| 08/23/2006 | CN1822826A Compounds and methods for delivery of prostacyclin analogs |
| 08/23/2006 | CN1822825A Treatment of anxiety disorders |
| 08/23/2006 | CN1822824A Method of treating degenerative disc disease |
| 08/23/2006 | CN1822823A Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease |
| 08/23/2006 | CN1822820A Treatment and prevention of cardiovascular events |
| 08/23/2006 | CN1822819A Oral controlled release forms useful for reducing or preventing nicotine cravings |
| 08/23/2006 | CN1822818A Particles containing an acitve agent in the form of a co-precipitate |
| 08/23/2006 | CN1822817A Inhalable formulations for treating pulmonary hypertension and methods of using same |
| 08/23/2006 | CN1822767A Antimicrobial reagent containing patchouli oil, patchouli alcohol or their derivatives |
| 08/23/2006 | CN1822765A Delivery of compounds with rehydrated blood cells |
| 08/23/2006 | CN1821377A Rheology modifier for aqueous systems |
| 08/23/2006 | CN1821278A Opacifying polymers |
| 08/23/2006 | CN1821275A Ginseng extracting method for separating ginseng polyose and extract and use of ginseng polyose |
| 08/23/2006 | CN1821262A Lonicera macranthoides active total saponin extract and its preparing method and use |
| 08/23/2006 | CN1821256A I*-salidroside and its preparation and use in anti-senile dimentia medicine |
| 08/23/2006 | CN1821255A Total giamt St.John' swort Herb flavone extract, its preparing method and use |
| 08/23/2006 | CN1821253A Novel water soluble Pt (II) anti-cancer ligand and its preparing method |
| 08/23/2006 | CN1821250A 1H-pyranyl[3,4d][1,2,3] tri-azonyl-4-ketonic compound, synthetic method and use |
| 08/23/2006 | CN1821249A Crystal-free type Idi prone and its preparing method |
| 08/23/2006 | CN1821243A Substituted pyridine M receptor excitomotor, its preparing process and its use |
| 08/23/2006 | CN1821241A Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/23/2006 | CN1821236A Therapeutic heterocyclic compounds |
| 08/23/2006 | CN1821202A Active compound bulbophyllum phenanthrene dimer A and its use |
| 08/23/2006 | CN1821201A Active compound bulbophyllum phenanthrene dimer B and its use |
| 08/23/2006 | CN1820785A Anti-tumor medicine |
| 08/23/2006 | CN1820781A Use of compound PS-341 in preparing medicine for treating chronic granulocytic leukemia |
| 08/23/2006 | CN1820773A Chinese medicine composition for treating oral inflammation and its preparation |
| 08/23/2006 | CN1820761A Chonsurid for venous injection administration and its preparing method |
| 08/23/2006 | CN1820760A Method for preparing kitasamycin tartrate injection |
| 08/23/2006 | CN1820759A Tacrolimus solid dispersion and its preparing method |
| 08/23/2006 | CN1820758A Method for preparing medicinal grade cane sugar |
| 08/23/2006 | CN1820757A Polyene phosphatidylcholine freeze-dried preparation injection and its preparing method |
| 08/23/2006 | CN1820756A Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 08/23/2006 | CN1820755A Medicinal composition of cefuroxime and ambroxol hydrochloride |
| 08/23/2006 | CN1820754A Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 08/23/2006 | CN1820753A Freeze-dried powder injection containing leucovorin sodium and its preparing method |
| 08/23/2006 | CN1820752A Oral liquor slow releasing preparation containing codeine and chlorophenamine and its preparing method |
| 08/23/2006 | CN1820751A Tirofiban powder injection and its preparing method |
| 08/23/2006 | CN1820750A Amoxycillin preparation suitable for child administration and its preparing method |
| 08/23/2006 | CN1820749A Formula of amoxycillin sodium/ambroxo/ hydrochloride powder injection and its preparing method |
| 08/23/2006 | CN1820748A Levo-ornidazole freeze-dried powder injection |
| 08/23/2006 | CN1820747A Injectable long-acting analgesic composition comprising an ester derivative of ketorolac |
| 08/23/2006 | CN1820746A Stepronin powder injection and its preparing method |
| 08/23/2006 | CN1820745A Stepronin injection and its preparing method |
| 08/23/2006 | CN1820744A Oseltamivir phosphate granula and its preparing method |
| 08/23/2006 | CN1820743A Inhibitor or promoter of uridinediphosphate glucuronosyltransferase 2B (UGT2B) |
| 08/23/2006 | CN1820742A Medicinal Composition of ferulate and chuanxiongqine salt |
| 08/23/2006 | CN1820741A Process for producing 1,4-dihydroxy-2-naphthoic acid |
| 08/23/2006 | CN1820740A Oral liquor for supplementing calcium and zinc and preparing method |
| 08/23/2006 | CN1820739A Sibutramine hydrochloride chewing tablet and its preparing method |
| 08/23/2006 | CN1820738A Tramadol hydrochloride slow release dripping pill and its preparing method |
| 08/23/2006 | CN1820737A Prescription and prepn of butyl boron gargle for anti-inflammation and stopping pain |
| 08/23/2006 | CN1820736A Use of 1,4-naphthalene diphenol in preparing external use sperm killing contraceptive medicine of preventing and curing genital tract infection |
| 08/23/2006 | CN1820734A Treatment with anti-erbb2 antibodies |
| 08/23/2006 | CN1820616A Biological health tea |
| 08/23/2006 | CN1271096C Alkylation of cross-linked polymers contg. N-or amino-or mamonium groups |
| 08/23/2006 | CN1271086C GLP-1 derivs. |
| 08/23/2006 | CN1271083C Composition, extraction process and use of total triterpene sapogenin extracted from bamboo |
| 08/23/2006 | CN1271082C Sulfonated sterol, preparing method and application |
| 08/23/2006 | CN1271073C Crystalline anti-cholinergic tiotropium crystal |
| 08/23/2006 | CN1271072C Process for the preparation of 14-hydroxymorphine derivatives |
| 08/23/2006 | CN1271070C Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine A2a receptor and their use as medicaments |
| 08/23/2006 | CN1271067C Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce TNF & alpha levels |
| 08/23/2006 | CN1271066C Aromatic dicarboxylic acid derivatives |
| 08/23/2006 | CN1271063C Di (5-formylfurfuryl) ether derivatives, preparations thereof and their uses in medicines |
| 08/23/2006 | CN1271061C Process for the preparation of the 14beta-hydroxy-baccatin III -1,14-carbonate |
| 08/23/2006 | CN1271055C Urea and thiourea derivatives as non-nucleoside reverse transcriptase inhibitors |
| 08/23/2006 | CN1271054C Urea compounds having muscarinic receptor antagonist activity |
| 08/23/2006 | CN1271052C Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
| 08/23/2006 | CN1270780C 栓塞材料 Embolic material |
| 08/23/2006 | CN1270777C Addition agent of pyrithioxine hydrochloride utilized for injection |
| 08/23/2006 | CN1270775C Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enbancing agents |
| 08/23/2006 | CN1270774C Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 08/23/2006 | CN1270754C Gastropathy treating medicine and its preparation |
| 08/23/2006 | CN1270742C Antiseptic Chinese medicine composition and its prepn process |
| 08/23/2006 | CN1270739C Freeze drying powder containing red ginseng and method for preparing the same |
| 08/23/2006 | CN1270735C Externally applied ointment for treating infantile diarrhea |
| 08/23/2006 | CN1270731C Composition for adjusting blood fat and preparing method thereof |
| 08/23/2006 | CN1270724C Drugs for ameliorating postcibal hyperglycaemia |
| 08/23/2006 | CN1270723C Azithromycin injection and its preparation |
| 08/23/2006 | CN1270722C Use of New Zealand vitexin-1 in preparing antiviral medicine |
| 08/23/2006 | CN1270721C Rapid disintegration and rapid dissolution tablet containing kakonein |
| 08/23/2006 | CN1270720C Yolk lecithin for injection and method for making same |
| 08/23/2006 | CN1270719C Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 08/23/2006 | CN1270718C Epiallopregnanolone in the treatment of CNS disorders |
| 08/23/2006 | CN1270717C Galantamin sustained release preparation and preparing process |
| 08/23/2006 | CN1270716C Freezing-drying powder-injection contg. sodium folinate, and its prepn. method |
| 08/23/2006 | CN1270715C Medicinal preparation of general alkaloid of bocconia cordata and producing method |
| 08/23/2006 | CN1270714C Microemulsion preconcentrates containing piperidine substance P antagonist |
| 08/23/2006 | CN1270713C Synergistic pharmaceutical combination for prevention or treatment of diabetes |
| 08/23/2006 | CN1270712C Felodipine controlled-release preparation |